The assessment of the serum levels of TWEAK and prostaglandin F2α in COVID – 19
Article
[키워드] aberrant immune response
acute respiratory syndrome
age
Apoptosis
Asymptomatic
asymptomatic patient
C-reactive protein
claimed
control group
coronavirus
COVID
COVID-19
Cytopathic effect
diagnosed with COVID-19
ferritin
fibrinogen
healthy volunteers
immune response
inducer
Inflammation
inhibition
involved
leukotrienes
lung involvement
lymphocyte
material
morbidity and mortality
Necrosis
occur
pathology
pathway
Patient
prostaglandin
Result
SARS-CoV-2
SARS-COV-2 infection
Serum level
Support
the healthy
Treatment
TWEAK
virus
was determined
with COVID-19
[DOI] 10.3906/sag-2006-96 PMC 바로가기 [Article Type] Article
[DOI] 10.3906/sag-2006-96 PMC 바로가기 [Article Type] Article